How do I buy Lilly (LLY) stock?

Buying Lilly (LLY) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "LLY", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy LLY by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if LLY is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Lilly (LLY) Stock

Q: What is the minimum investment for LLY on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Lilly from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · LLY

Trade LLY

Key stats

Market cap: $1.26T
Price / Earnings ratio: 48.1x
EPS (TTM): $30.85
Volume: Loading
52-week high: $1449.68
52-week low: $850.51
Dividend yield: 0.47%
Dividend amount (latest): $1.73
EPS vs analyst estimate: +17.8%Q3 FY25 · $7.02 vs $5.96

Source: third-party data provider, as of November 5, 2026

EPS estimate: analyst consensus

Compare with LLY

Technical indicators

RSI 14: 76.56
MACD 12/26/9: 59.23
EMA 9 of MACD: 44.06
MACD histogram: 15.17
SMA 50: $1,207.19; Price above SMA 50
EMA 50: $1,239.12; Price above EMA 50
SMA 200: $1,096.87; Price above SMA 200
EMA 200: $1,119.67; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 15 analyst ratings

Strong Sell0

Sell1

Hold0

Buy14

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

78B52B26B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

135B89B45B0

Revenue to Profit

2025

$65.2B

Revenue

$0.0

Cost of revenue

$54.1B

Gross profit

$0.0

Operating expenses

$20.6B

Net income

Earnings

EPS forecast

Actual EPS

$7.02

$5.96

Q3FY25

$7.29

Q4FY25

$7.64

Q1FY26

$8.38

Q2FY26

$9.50

Q3FY26

The market is expecting earnings per share of $9.50 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Lilly

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better."

SectorHealthcare

IndustryDrug Manufacturers - General

Employees50,000

CEOMr. David A. Ricks

IPO DateJan 13, 1978

HeadquartersIndianapolis, IN

Key Executives

Name	Title	Year Born
Mr. David A. Ricks	Chairman, President & CEO	1968
Mr. Lucas E. Montarce	Executive VP & CFO	1977
Dr. Daniel M. Skovronsky M.D., Ph.D.	Chief Scientific & Product Officer and President of Lilly Research Laboratories	1973
Ms. Anat Hakim J.D.	Executive VP, General Counsel & Secretary	1969
Mr. Jacob S. Van Naarden	Executive VP, President of Lilly Oncology & Head of Corporate Business Development	1985
Mr. Donald A. Zakrowski	Senior VP of Finance & Chief Accounting Officer	—
Mr. Diogo Rau	Executive VP and Chief Information & Digital Officer	1975
Mr. Michael Czapar	Senior Vice President of Investor Relations	—
Mr. Eric Dozier	Executive VP & Chief People Officer	1967
Mr. Ilya Yuffa	Executive VP and President of Lilly USA & Global Customer Capabilities	1975

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-6.4	+10.9
2022	-9.7	+0.7	+14.8	-0.2	+8.2	+4.2	+1.5	-7.1	+4.6	+12.6	+5.2	-1.2
2023	-5.7	-9.2	+9.3	+12.9	+5.8	+7.4	-1.5	+22.3	-3.6	+2.9	+6.6	-0.2
2024	+9.0	+14.1	-0.5	+2.7	+5.6	+8.9	-12.0	+15.3	-7.4	-6.2	-2.9	-3.5
2025	+4.2	+13.6	-11.2	+11.6	-7.1	+4.3	-4.6	-3.9	+3.8	+4.5	+20.0	+1.6
2026	-4.0	+0.8	-9.6	-2.1	+14.7	+10.8	-3.6	+3.2	-0.3	+23.3	-0.1

Stocks in the same sector

FAQ

Buying Lilly (LLY) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "LLY", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy LLY by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Lilly from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Lilly regularly pays dividends to shareholders. Currently, the estimated dividend yield for LLY is around 0.47% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Lilly (LLY) Stock

Key stats

Compare with LLY

Recent news

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?

LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?

Eli Lilly Just Delivered Another Monster Quarter. But There's More to This Story Than Weight-Loss Drugs

Eli Lilly Just Delivered Another Monster Quarter. But There's More to This Story Than Weight-Loss Drugs

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?

LLY Stock Up Almost 10% After a Robust Q3: Time to Buy, Sell or Hold?

Eli Lilly Just Delivered Another Monster Quarter. But There's More to This Story Than Weight-Loss Drugs

Eli Lilly Just Delivered Another Monster Quarter. But There's More to This Story Than Weight-Loss Drugs

Eli Lilly Stock: Is It Still a Buy at $1,400?

Eli Lilly Stock: Is It Still a Buy at $1,400?

Eli Lilly Just Delivered Another Blowout Quarter. Is This Unstoppable Growth Stock Still a Buy?

Eli Lilly Just Delivered Another Blowout Quarter. Is This Unstoppable Growth Stock Still a Buy?

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?

After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?

$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%

$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%

Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030

Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030

About Lilly

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade